ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000730.1|Capsular_1 # 3 # 149 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.429	BGC0000730.1|Capsular_1 	3	149	+	Loose	500	21.557	ErmF	41.94	3000498	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	AGGGAGTTGTGTGTATTCTTTTACGTGACAGTGAATTTAAGAATTTGGCGGGCAGATGCCCGGGCAGTATCCGTGTATTATCAGTTCCAATGGATTTGTGACATGTACAATTTTGCAAAACCGCGTGTTTTGCAACCAAACAGGTGA	RELCVFFYVTVNLRIWRADARAVSVYYQFQWICDMYNFAKPRVLQPNR	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	18.05	gnl|BL_ORD_ID|568|hsp_num:0	621			207	285	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000730.1|Capsular_2 # 194 # 1084 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGCAG;rbs_spacer=5bp;gc_cont=0.600	BGC0000730.1|Capsular_2 	194	1084	-	Loose	400	26.1794	VIM-13	55.56	3002283	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGTTCACGCCCTGCCCCCCGGCACTACGCTGGCGCTCAGGCCAGCAGTTTTTTAATGCTTTCGCGGAATTTGGTGCCTTCTTTCAGGTTACGCATCCCGTAGGTGACGAAGGCTTGCATGTAGCCCATTTTCTTCCCGCAGTCGTAGCTTTCGCCGGTCATCAGCATCGCGTCGACGGACTGCTTCTTCGCCAGTTCGGCAATGGCGTCGGTCAGCTGGATACGGCCCCATGCGCCCGGCTCGGTACGTTCCAGTTCGGCCCAGATATCCGCCGACAGCACGTAGCGCCCCACCGCCATCAGATCGGAGTCCAGGGTCTGCGGTTCGTCCGGTTTTTCAATAAACTCAACGATACGCGCCACCTGGCCTTCAGCCACCATCGGCTCTTTGGTCTGGATGACGGAGTATTCGGAGAGATCGCCCGGCATGCGTTTCGCCAGCACCTGGCTGCGGCCGGTCTCGTTAAAGCGGGCGATCATAGCGGCGAGGTTATAGCGCAGCGGGTCAGCGGTGCCGCCGTCAAGGATGATATCCGGCAGGACCACCACAAACGGGTTGTCGCCGACTACCGGGCGGGCGCAGAGGATGGAGTGGCCCAGGCCCAGCGGCTGCGCCTGACGCACGTTCATGATGGTCACGCCCGGCGGGCAAATGGCCTGCACTTCCGCCAGCAGCTGGCGCTTCACGCGCTGTTCCAGCAGGGCTTCCAGCTCGTAGGAGGTATCGAAGTGGTTTTCCACCGCGTTCTTCGAGGAGTGCGTCACCAGAACAATCTCTTTGATCCCGGCGGCGACGATTTCGTCAACGATGTACTGAATCATTGGCTTATCAACGATCGGCAGCATCTCCTTTGGAATTGCCTTTGTGGCCGGCAGCATATGCATGCCTAG	MFTPCPPALRWRSGQQFFNAFAEFGAFFQVTHPVGDEGLHVAHFLPAVVAFAGHQHRVDGLLLRQFGNGVGQLDTAPCARLGTFQFGPDIRRQHVAPHRHQIGVQGLRFVRFFNKLNDTRHLAFSHHRLFGLDDGVFGEIARHAFRQHLAAAGLVKAGDHSGEVIAQRVSGAAVKDDIRQDHHKRVVADYRAGAEDGVAQAQRLRLTHVHDGHARRANGLHFRQQLALHALFQQGFQLVGGIEVVFHRVLRGVRHQNNLFDPGGDDFVNDVLNHWLINDRQHLLWNCLCGRQHMHA	MLKVISSLLFYMTASLMAVASPLAHSGESRGEYPTVSEIPVGEVRLYQIDDGVWSHIATHTFDGVVYPSNGLIVRDGDELLLIDTAWGTKNTVALLAEIEKQIGLPVTRSVSTHFHDDRVGGVDALRAAGVATYASPSTRRLAEAEGNEVPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAVLELSRTSAGNVADADLAEWPGSVERIQQHYPEAEVVIPGHGLPGGLDLLQHTANVVKAHTNRSVAE	111.28	gnl|BL_ORD_ID|1429|hsp_num:0	1556			132	186	
BGC0000730.1|Capsular_3 # 1486 # 2409 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.541	BGC0000730.1|Capsular_3 	1486	2409	-	Loose	600	25.7942	TLA-2	29.79	3003203	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; cephalosporin	antibiotic inactivation	TLA beta-lactamase	GTGGCAAAGCAAAAGTTCAAAATCACCAACTGGCCCACCTACAATAAAGCCCTCATCAACCGTGGCTCCATAACTTTCTGGCTGGATGATGAAGCTATTCAGGCCTGGTATGAGTCGGCAGCGCCTTCTTCACGAGGCAGACCTCAGCGCTATTCTGACCTTGCCATCACGACTGTGCTGGTCATTAAACGCGTATTCAGGCTGACCCTGCGCGCTGCGCAGGGCTTTATTGATTCCATTTTTTCTCTGATGAACGTTCCGCTACGCTGCCCGGATTACAGCTGTGTCAGCAGGCGGGCAAAGTCGGTTAATGTCAGTTTCAAAACGCCCACCCGGGGTGAAATCGCACACCTGGTAATTGATTCCACCGGGCTGAAGGTCTTCGGTGAAGGCGAGTGGAAAGTCAAAAAGCATGGCCAGGAACGCCGCCGTATCTGGCGTAAGCTGCATCTCGCCGTTGACAGTAAAACACATGAAATTATCTGCGCTGACCTGTCGCTGAACAACGTTACGGACTCAGAGGCCTTCCCCGGGTTAATCCGGCAAACCCACCGGAAAATCAGGTCAGCCGCCGCCGATGGCGCTTACGATACCCGGCTATGTCACGATGAACTGCGGCGTAAGAAAATCAGCGCGCTTATCCCACCCCGAAAAGGTGCGGGTTACTGGCCCGGTGAATATGCAGACCGTAACCGTGCAGTGGCTAATCAGCGAATGACCGGGAGTAATGCGCGGTGGAAATGGACAACAGATTACAACCGTCGCTCGATAGCGGAAACGGCGATGTACCGGGTAAAACAGCTGTTCGGGGGTTCACTGACGCTGCGTGACTACGATGGTCAGGTTGCGGAGGCTATGGCCCTGGTACGAGCGCTGAACAAAATGACGAAAGCAGGTATGCCTGAAAGCGTGCGTATTGCCTGA	MAKQKFKITNWPTYNKALINRGSITFWLDDEAIQAWYESAAPSSRGRPQRYSDLAITTVLVIKRVFRLTLRAAQGFIDSIFSLMNVPLRCPDYSCVSRRAKSVNVSFKTPTRGEIAHLVIDSTGLKVFGEGEWKVKKHGQERRRIWRKLHLAVDSKTHEIICADLSLNNVTDSEAFPGLIRQTHRKIRSAAADGAYDTRLCHDELRRKKISALIPPRKGAGYWPGEYADRNRAVANQRMTGSNARWKWTTDYNRRSIAETAMYRVKQLFGGSLTLRDYDGQVAEAMALVRALNKMTKAGMPESVRIA	MNIKYFKFAEKFILLVLIMSFSSLAFCKSDDSLEQRINSIISGKKASVGVAVAGIEDNFSLSINGKKNFPMMSVYKLHIVLAVLNKVDGGSLKLDEKIPLNKKDLHPGTWSPLRDKYPNGGVSIPLSEIIEYTITQSDNNGCDILIALAGGTEAVKRYIISKGISDFDIRATEKECHESWNVQYSNWSTPVSAVALLKKFNDRKILSSVSTEYLMNVMIHTSTGNKRIKGLIPPSADVAHKTGTSGIRNGITPGTNDIGIVTLPNGKHFAIAVFVSDSRENNAANERIIAEISKAAWDYFVKMN	100.99	gnl|BL_ORD_ID|87|hsp_num:0	102			606	747	
BGC0000730.1|Capsular_5 # 2888 # 3136 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.574	BGC0000730.1|Capsular_5 	2888	3136	+	Loose	700	24.6386	MOX-7	33.96	3002189	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	MOX beta-lactamase	GTGATTGCCGGCCTGCTGCTGGGCGCTGCTGGCAGCGCTTTGTTCCTGGTGTTGCAAAAACGTACCTCTGATCCGGAAAGCGTGAATATCTCATGGGGCGGTGTCGCATGCCTGGTGATGGTTCCACTTATCCTTTTACATAGCGGTAGCAAAGCGCCGACTCAGTCCCTGCTGGGACAAATCGCCACCGCGGTGGGGCCGCTGGATAAACCCTTTACGCGTACCGATCTGCACAAGCAGGCCTGGTAA	MIAGLLLGAAGSALFLVLQKRTSDPESVNISWGGVACLVMVPLILLHSGSKAPTQSLLGQIATAVGPLDKPFTRTDLHKQAW	MQQRQSILWGALATLMWAGLVHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDGKAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGSFELDDKASLFAPWLKGSVFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPSIGLFGYLAASSMKQPFDRLMEQTMLPGLGLYHTYLTVPEQAMGHYAYGYSKEDKPIRVTPGMLADEAYGIKTSSADLLRFVKANIGGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYAYPVSEQTLLAGNSPAMIYNAIPAVPAPAAAGHPVLFNKTGSTNGFGAYVAFVPAKGIGIVMLANRNSPIEARIKAAHAILTQLAR	21.41	gnl|BL_ORD_ID|1507|hsp_num:0	1637			0	135	
BGC0000730.1|Capsular_6 # 3390 # 4313 # -1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.541	BGC0000730.1|Capsular_6 	3390	4313	-	Loose	600	25.7942	TLA-2	29.79	3003203	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; cephalosporin	antibiotic inactivation	TLA beta-lactamase	GTGGCAAAGCAAAAGTTCAAAATCACCAACTGGCCCACCTACAATAAAGCCCTCATCAACCGTGGCTCCATAACTTTCTGGCTGGATGATGAAGCTATTCAGGCCTGGTATGAGTCGGCAGCGCCTTCTTCACGAGGCAGACCTCAGCGCTATTCTGACCTTGCCATCACGACTGTGCTGGTCATTAAACGCGTATTCAGGCTGACCCTGCGCGCTGCGCAGGGCTTTATTGATTCCATTTTTTCTCTGATGAACGTTCCGCTACGCTGCCCGGATTACAGCTGTGTCAGCAGGCGGGCAAAGTCGGTTAATGTCAGTTTCAAAACGCCCACCCGGGGTGAAATCGCACACCTGGTAATTGATTCCACCGGGCTGAAGGTCTTCGGTGAAGGCGAGTGGAAAGTCAAAAAGCATGGCCAGGAACGCCGCCGTATCTGGCGTAAGCTGCATCTCGCCGTTGACAGTAAAACACATGAAATTATCTGCGCTGACCTGTCGCTGAACAACGTTACGGACTCAGAGGCCTTCCCCGGGTTAATCCGGCAAACCCACCGGAAAATCAGGTCAGCCGCCGCCGATGGCGCTTACGATACCCGGCTATGTCACGATGAACTGCGGCGTAAGAAAATCAGCGCGCTTATCCCACCCCGAAAAGGTGCGGGTTACTGGCCCGGTGAATATGCAGACCGTAACCGTGCAGTGGCTAATCAGCGAATGACCGGGAGTAATGCGCGGTGGAAATGGACAACAGATTACAACCGTCGCTCGATAGCGGAAACGGCGATGTACCGGGTAAAACAGCTGTTCGGGGGTTCACTGACGCTGCGTGACTACGATGGTCAGGTTGCGGAGGCTATGGCCCTGGTACGAGCGCTGAACAAAATGACGAAAGCAGGTATGCCTGAAAGCGTGCGTATTGCCTGA	MAKQKFKITNWPTYNKALINRGSITFWLDDEAIQAWYESAAPSSRGRPQRYSDLAITTVLVIKRVFRLTLRAAQGFIDSIFSLMNVPLRCPDYSCVSRRAKSVNVSFKTPTRGEIAHLVIDSTGLKVFGEGEWKVKKHGQERRRIWRKLHLAVDSKTHEIICADLSLNNVTDSEAFPGLIRQTHRKIRSAAADGAYDTRLCHDELRRKKISALIPPRKGAGYWPGEYADRNRAVANQRMTGSNARWKWTTDYNRRSIAETAMYRVKQLFGGSLTLRDYDGQVAEAMALVRALNKMTKAGMPESVRIA	MNIKYFKFAEKFILLVLIMSFSSLAFCKSDDSLEQRINSIISGKKASVGVAVAGIEDNFSLSINGKKNFPMMSVYKLHIVLAVLNKVDGGSLKLDEKIPLNKKDLHPGTWSPLRDKYPNGGVSIPLSEIIEYTITQSDNNGCDILIALAGGTEAVKRYIISKGISDFDIRATEKECHESWNVQYSNWSTPVSAVALLKKFNDRKILSSVSTEYLMNVMIHTSTGNKRIKGLIPPSADVAHKTGTSGIRNGITPGTNDIGIVTLPNGKHFAIAVFVSDSRENNAANERIIAEISKAAWDYFVKMN	100.99	gnl|BL_ORD_ID|87|hsp_num:0	102			606	747	
BGC0000730.1|Capsular_7 # 5930 # 6601 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.506	BGC0000730.1|Capsular_7 	5930	6601	+	Loose	400	24.2534	QnrD1	42.11	3002788	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	ATGCAGTGGGGTGGAAAAGGGCGGCCTGAATCACTCAGTAACTTCTGGGATGGTTTAACAGGCAAGGATAATACCGCCGCAAACGATCCCAATGAACCAGGGAACCAACTGGCCGGTTTTGACTTTAAGTTCAAATTGGAGCCGACCCTGGGCTGGCCGGTGAGCTTCTACGGGCAGATGATTGGCGAAGATGAGTCTGGTTTCCTGCCTTCAGCAAATATGTTCCTCGGCGGGATTGAAGGGCACCACGGCTGGGGTAAGGATGCGGTTAACTGGTACCTGGAAGCGCATGATACTCGTACCAATATGAGCCGGACCAATTACAGTTATACGCATCATATCTATAAGGATGGCTACTATCAGCAGGGTTATCCTCTGGGTGACGCAATGGGCGGGGATGGTCAACTCGTTGCCGGTAAGGTTGAGCTTATTACGGAGGATAACCAGCGCTGGAGTACACGCTTAGTATACGCGAAGGTCAACCCGGAGAATCAGTCGATCAACAAAGCATTCCCTCATGCGGATACTCTTAAAGGTATACAGCTTGGCTGGAGCGGGGATGTTTATCAGTCGGTTCGTTTGAATACTTCACTGTGGTACACCAACGCTAATAACAGCGACAGCGACGACGTTGGGGCCAGCGCAGGGATTGAAATACCGTTTAGTTTATAA	MQWGGKGRPESLSNFWDGLTGKDNTAANDPNEPGNQLAGFDFKFKLEPTLGWPVSFYGQMIGEDESGFLPSANMFLGGIEGHHGWGKDAVNWYLEAHDTRTNMSRTNYSYTHHIYKDGYYQQGYPLGDAMGGDGQLVAGKVELITEDNQRWSTRLVYAKVNPENQSINKAFPHADTLKGIQLGWSGDVYQSVRLNTSLWYTNANNSDSDDVGASAGIEIPFSL	MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRINLDGVKLDGEQALQLVESLGVIVHR	104.21	gnl|BL_ORD_ID|758|hsp_num:0	822			324	381	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0000730.1|Capsular_8 # 6746 # 7885 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.413	BGC0000730.1|Capsular_8 	6746	7885	+	Loose	300	27.7202	AAC(3)-IXa	24.62	3002543	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGAAGAAAAAACTTGTTAGATTTTCGGCATTAGCATTGGCGATTGGGTTTTTATCGGGTTGTACAATCATCCCTGGTCAGGGATTGAACAGTCTGCGTAAAAACGTGGTAGAACTCCCGGATAGCGACTACGATTTGGATAAGCTGGTGAATGTTTATCCTATGACGCCAGGTCTAATAGATCAACTCCGTCCGGAACCGGTTATAGCACGCTCGAATCCTCAGTTGGATAACCTATTAAAAAGTTATGAGTATCGCATTGGTGTGGGTGATGTGCTCATGGTTACGGTATGGGATCATCCGGAATTAACGACACCTGCTGGTCAATATCGTAGTGCAAGTGATACGGGTAACTGGGTAAATTCTGACGGAACAATTTTTTATCCTTACATAGGTAAGGTTCAGGTAGCTGGAAAAACAGTAAGTCAAGTACGACAAGATATTACAAGCCGATTAACCACATATATTGAAAGCCCTCAAGTTGATGTCAGCATAGCTGCATTCCGGTCACAAAAGGTTTATGTAACTGGTGAAGTTGCAAACTCTGGAAAACAGGCTATTACAAATATTCCCCTAACTGTGATGGATGCTATCAATGCGGCAGGAGGGCTTGCGGCTGATGCTGACTGGAGAAACGTTGTTCTTACTCATAACGGTAAAGATACAAAGATTTCATTATATGCACTAATGCAGAAAGGAGATCTAACCCAGAATCATTTATTATACCCTGGCGATATATTATTCATTCCACGTAATGATGATCTCAAAGTATTTGTCATGGGAGAGGTCGGTAAGCAAAGTACATTGAAAATGGACCGCAGCGGTATGACCCTTGCAGAGGCGCTTGGTAATGCTGAGGGTATTTCTCAAGAAATGAGCGATGCTACAGGGATATTTGTTGTACGTCAGTTAAAAGGTGATAGGACAGGAAAAATAGCAGATATATACCAATTGAATGCTCAGGATGCTTCAGCAATGGTCTTAGGTACAGAATTTCAACTACAACCTTATGACATTGTATATGTAACGACTGCACCTCTTGTTCGTTGGAATCGTGTTATATCACAGCTCGTACCTACAATATCAGGTGTTCATGATATGACGGAAACAGTACGATACATTAAGAGATGGCCAAACTAA	MKKKLVRFSALALAIGFLSGCTIIPGQGLNSLRKNVVELPDSDYDLDKLVNVYPMTPGLIDQLRPEPVIARSNPQLDNLLKSYEYRIGVGDVLMVTVWDHPELTTPAGQYRSASDTGNWVNSDGTIFYPYIGKVQVAGKTVSQVRQDITSRLTTYIESPQVDVSIAAFRSQKVYVTGEVANSGKQAITNIPLTVMDAINAAGGLAADADWRNVVLTHNGKDTKISLYALMQKGDLTQNHLLYPGDILFIPRNDDLKVFVMGEVGKQSTLKMDRSGMTLAEALGNAEGISQEMSDATGIFVVRQLKGDRTGKIADIYQLNAQDASAMVLGTEFQLQPYDIVYVTTAPLVRWNRVISQLVPTISGVHDMTETVRYIKRWPN	MEEMSLLNHSGGPVTRSRIKHDLADLGLKDGDVVIFHTRMSAIGYVAGGTQTIIGALLDVVGARGTLMVPCGWNNAPPYDFLDWPRDWQDALRAEHPAYDPDLSEADYNNGRLPEALPRWPGAIRSRHPDASFAALGPAAAELMAEHPWDHPHGPDTPLARLIAHSGRVLLLGAPLDTMTLLHHAEALADVRSKRFVTYEQPILVNGQRVWRQFRDIDSEEGAFDYSTVRRGVEPFEAIARDMLSAGIGRQGRVGAADSYLFDAGPVFNFAINWIEAKLKR	134.88	gnl|BL_ORD_ID|1870|hsp_num:0	2030			303	459	neomycin
BGC0000730.1|Capsular_9 # 7873 # 8319 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.423	BGC0000730.1|Capsular_9 	7873	8319	+	Loose	375	25.0238	nalD	29.87	3000819	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCAAACTAATGTTTGATTCAATTTTAGTGATCTGCACAGGAAATATCTGCCGTTCTCCAATTGGTGAGCGTTTATTAAGACGGCTATTACCAAGCAAAAAGATTAATTCCGCTGGGGTTGGGGCATTGGTTGATCATGCAGCAGATGAATCCGCAATTCGCGTCGCTGAAAAAAATGGTCTTTGTCTCAAAGGCCACCGTGGGACAAAATTTACCTCTGCATTAGCTCGACAGTATGATCTTTTACTCGTGATGGAATATTCTCATCTAGAACAAATTAGCCGGATAGCACCTGAAGCACGTGGTAAAACTATGCTGTTTGGACACTGGCTTGATAGTAAAGAAATCCCAGACCCATACCGTATGAGTGATGAAGCATTCGACTCGGTATATCAATTGCTTGAACAAGCAAGCAAGCGTTGGGCTGAGAAATTAGGTGAATAA	MAKLMFDSILVICTGNICRSPIGERLLRRLLPSKKINSAGVGALVDHAADESAIRVAEKNGLCLKGHRGTKFTSALARQYDLLLVMEYSHLEQISRIAPEARGKTMLFGHWLDSKEIPDPYRMSDEAFDSVYQLLEQASKRWAEKLGE	MRRTKEDSEKTRTAILLAAEELFLEKGVSHTSLEQIARAAGVTRGAVYWHFQNKAHLFNEMLNQVRLPPEQLTERLSGCDGSDPLRSLYDLCLEAVQSLLTQEKKRRILTILMQRCEFTEELREAQERNNAFVQMFIELCEQLFARDECRVRLHPGMTPRIASRALHALILGLFNDWLRDPRLFDPDTDAEHLLEPMFRGLVRDWGQASSAP	69.81	gnl|BL_ORD_ID|2335|hsp_num:0	1213			87	318	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; panipenem; ticarcillin; trimethoprim-sulfamethoxazole
BGC0000730.1|Capsular_10 # 8337 # 10508 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAA;rbs_spacer=7bp;gc_cont=0.367	BGC0000730.1|Capsular_10 	8337	10508	+	Loose	900	28.8758	TolC	32.94	3000237	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACTTCAGTCACATCTAAGAAATCAACGATACTAGGATCTGATGAAATAGATTTAGGTCGCGTTATCGGTGAGCTAATTGATCATCGTAAGCTTATTATATCTATAACATCGGTTTTTACCTTATTTGCAATACTCTATGCATTATTAGCGACTCCTATCTATGAGACGGATGCGCTAATTCAAATAGAGCAGAAGCAAGGTAATGCTATACTAAGCAGTCTAAGTCAGGTTTTACCTGATGGCCAACCCCAATCTGCACCTGAAACAGCTTTGCTACAATCTCGAATGATTCTTGGCAAAACTATAGATGATTTAAACCTTCAGATTCAAATTAAACAAAAATATTTTCCTGTTATTGGCCGTGGGTTAGCAAGATTAATGGGAGAAAAACCAGGTAATATTGATATTACTCGGTTATATTTGCCTGGTAGTGACGATATTAGTAATAATACTCCTAGTATAATATTAACAGTAAAAGATAAAGAAAATTATTCGATCAATAGTGATGGTATTCAACTCAATGGGGTTGTAGGGACGTTATTAAATGAAAAAGGGATATCATTACTGGTTAACGAAATCGATGCTAAACCTGGAGATCAATTTGTTATTACACAGTTGCCTCGATTAAAGGCCATTTCTGATCTTTTAAAAAGTTTTAGCGTTGCTGATTTGGGTAAAGATACGGGAATGTTAACGTTGACTCTTACTGGAGATAACCCAAAAAGAATATCTCATATTTTGGACAGTATCAGTCAGAACTATCTTGCACAGAACATTGCTAGACAAGCTGCGCAGGATGCTAAAAGTCTCGAGTTTTTAAATCAACAATTACCCAAAGTTCGTGCCGAATTAGATTCTGCGGAAGACAAGTTAAATGCTTATCGTAAGCAAAAAGACTCTGTTGACTTGAATATGGAAGCTAAATCAGTACTTGATCAAATAGTTAACGTTGATAATCAACTAAATGAATTAACCTTCCGTGAGGCAGAAGTTTCACAGCTATATACTAAGGAACATCCTACTTATAAGGCGTTAATGGAAAAACGGCAAACACTTCAAGAAGAAAAATCTAAACTTAATAAGCGCGTTAGTAGTATGCCCTCGACCCAGCAGGAGGTTCTGCGATTAAGTCGAGATGTTGAATCTGGTCGTGCTGTATATTTGCAATTGCTAAATCGGCAACAAGAATTAAACATTGCCAAATCAAGTGCCATTGGCAACGTTAGAATTATTGATAATGCTGTAACAGATCCTAATCCTGTAAGACCAAAGAAGACTATCATAATTGTAATAGGTGTTGTTTTAGGGCTAATCGTTTCGGTTGTACTGGTATTGTTCCAAGTGTTTCTACGCCGTGGTATCGAATCCCCAGAGCAACTCGAAGAAATCGGAATAAACGTGTATGCAAGTATTCCAATATCTGAATGGCTTGCAAAAAATGCTCGTCAGTCAGGGAAAGTCAGAAAAAATCAGTCAGACACATTGCTTGCTGTTGGTAATCCTGCCGATTTAGCTGTTGAGGCCATTCGTGGTTTACGCACAAGTTTGCATTTTGCAATGATGGAAGCAAAAAATAATGTCCTAATGATATCGGGTGCTAGTCAAAGCGCAGGTAAAACTTTTATTAGCAATAACTTGGCAGCCACTATAGCAATTACAGGGAAAAAAGTTTTATTCATTGATGCTGACCTTCGTAAGGGATATGCTCATAAAATGTTTGGTCATAAAAACGATAAAGGATTATCTGAGTTTTTATCTGGACAAGCCGCTGCTGAAATGGTCATTGATAAAGTAGAAGGGGGGGAATTTGATTACATTGGTCGTGGACAAATTCCTCCAAACCCAGCTGAATTACTTATGCATCCGCGTTTTGAACAATTATTAAATTGGGCCTCACAAAATTATGATTTAATTATAATAGATACACCTCCAATTTTGGCAGTGACAGATGCTGCGATTATTGGTCGATATGCTGGAACATGTCTATTAGTCGCTCGCTTTGAAAAAAATACTGTTAAAGAAATTGATGTAAGTATGAAGCGGTTTGAGCAAAGTGGTGTGGTAGTCAAAGGCTGTATACTTAACGGTGTTGTAAAGAAAGCTAGCAGCTACTATGGATATGGTTATAATCATTATGGCTATTCTTATTCTGATAAAAAAATAGACTGA	MTSVTSKKSTILGSDEIDLGRVIGELIDHRKLIISITSVFTLFAILYALLATPIYETDALIQIEQKQGNAILSSLSQVLPDGQPQSAPETALLQSRMILGKTIDDLNLQIQIKQKYFPVIGRGLARLMGEKPGNIDITRLYLPGSDDISNNTPSIILTVKDKENYSINSDGIQLNGVVGTLLNEKGISLLVNEIDAKPGDQFVITQLPRLKAISDLLKSFSVADLGKDTGMLTLTLTGDNPKRISHILDSISQNYLAQNIARQAAQDAKSLEFLNQQLPKVRAELDSAEDKLNAYRKQKDSVDLNMEAKSVLDQIVNVDNQLNELTFREAEVSQLYTKEHPTYKALMEKRQTLQEEKSKLNKRVSSMPSTQQEVLRLSRDVESGRAVYLQLLNRQQELNIAKSSAIGNVRIIDNAVTDPNPVRPKKTIIIVIGVVLGLIVSVVLVLFQVFLRRGIESPEQLEEIGINVYASIPISEWLAKNARQSGKVRKNQSDTLLAVGNPADLAVEAIRGLRTSLHFAMMEAKNNVLMISGASQSAGKTFISNNLAATIAITGKKVLFIDADLRKGYAHKMFGHKNDKGLSEFLSGQAAAEMVIDKVEGGEFDYIGRGQIPPNPAELLMHPRFEQLLNWASQNYDLIIIDTPPILAVTDAAIIGRYAGTCLLVARFEKNTVKEIDVSMKRFEQSGVVVKGCILNGVVKKASSYYGYGYNHYGYSYSDKKID	MQMKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPLLPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTYQTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNARAQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNALLKEAEKRNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDDSNMGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQLNIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSARTTTSNGHNPFRN	146.06	gnl|BL_ORD_ID|4676|hsp_num:0	826			1239	1482	erythromycin; cloxacillin; gentamicin C; tigecycline; ciprofloxacin; spectinomycin; streptomycin; tetracycline; tobramycin; oxacillin; ceftazidime; ertapenem; piperacillin; novobiocin; azithromycin; rifampin; imipenem; chloramphenicol; polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4; ampicillin; nalidixic acid; norfloxacin; cefalotin; triclosan; ticarcillin; gentamicin
BGC0000730.1|Capsular_11 # 10583 # 12013 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.365	BGC0000730.1|Capsular_11 	10583	12013	+	Loose	540	26.5646	OXA-157	23.96	3001462	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACGCATTTGGCAAGAAACGTTAGCTGCAGTATTACACTTGCGGTAGTAGATTTCATTAGCTTAACTCTATCTCTATATTTAGCCTTAGGTGTACTATCATTAACTCTTGAGCATTTTCAACAGAGAGTTCCACAAGATCAAATCGAAGGGTGGATAGGTTTACATTGGTTATTAGGTGTCTGTTGTGTTGCTTGGTATGGTATTAGATTACGGCACTATTTTTATCGTAAAACATTTTGGTTTGAACTGAAAGAGATTTTACGCACACTTGTTATATTCGCTATCATTGAAGTTGCAATAATCGCTTTTGCAAAATGGTATTTTTCACGTTATGTCTGGTTAATGACGTGGGTTTTTGCTGCTGCATTAGTACCATTGTTACGTATGACAGCAAAATATATTTTAAATTCATTGGGATTATGGATGCGTGATACATGGATAATAGGGAATGGAAAAAATGCTCACGAGGCGTATAAAGCAATTAATAGCGAAAATAACCTTGGTTTAAATGTTGTTGGCTTTGTTGATGTAGATGACAATAATAATGGTTTCAATAATACTATTGATAGTGTCCAGGTAATAAGTGTTGATAAAACCTGGTTGACAACTGTTGATAAGCACACTCAATTTATAGTCGCTGTAGAGAGTCATCAAAGTGAAATTCGTAACAATTGGCTTCGCGAGTTTATGATTCGTGGTTATCGCTATGTATCAGTAATACCAACATTGCGAGGAATGCCATTGGATAGTACTGACATGTCATTTATATTCAGTCATGAAGTGATGATTTTTAGGGTGCAACAAAACCTAGCTAAATGGTCATCACGTGCTCTTAAGCGCACATTTGATATTGTTGGGTCCCTCTCGATAATAATAGTACTATCTCCTGTATTGCTATATATCAGTCAGAAAGTTAAAAAGGATGGTGGCTCTGCGATTTATGGGCATGAAAGGGTAGGTAAAGGTGGGAAGCCATTCAAATGTTTGAAGTTTCGTTCAATGGTCGTTAATTCAAAAGAGGTTCTGGAAAGGTTGTTGGAAAATGATCCTAAAGCAAAGGCTGAATGGGATGCCACATTTAAATTGAAAGATGACCCTCGTATTACTAAAATCGGACAATTTCTACGTCGAACAAGCCTTGACGAATTACCACAGTTGTTCAATGTCTTGAAAGGAGAAATGAGTCTTGTGGGGCCTCGCCCAATCATTACTGCTGAACTTGAACGCTATAATGATGAAGTAGATTACTATCTATTAAGTAAACCGGGAATGACAGGGTTATGGCAAGTTAGTGGCCGAAGTGATGTCGATTATGATACTCGTGTCTATTTAGATGCTTGGTATGTTAAAAATTGGTCAATGTGGAATGATATTGCTATATTATTTAAAACAATTGGCGTTGTACTTAAGAAAGATGGTGCTTATTAA	MTHLARNVSCSITLAVVDFISLTLSLYLALGVLSLTLEHFQQRVPQDQIEGWIGLHWLLGVCCVAWYGIRLRHYFYRKTFWFELKEILRTLVIFAIIEVAIIAFAKWYFSRYVWLMTWVFAAALVPLLRMTAKYILNSLGLWMRDTWIIGNGKNAHEAYKAINSENNLGLNVVGFVDVDDNNNGFNNTIDSVQVISVDKTWLTTVDKHTQFIVAVESHQSEIRNNWLREFMIRGYRYVSVIPTLRGMPLDSTDMSFIFSHEVMIFRVQQNLAKWSSRALKRTFDIVGSLSIIIVLSPVLLYISQKVKKDGGSAIYGHERVGKGGKPFKCLKFRSMVVNSKEVLERLLENDPKAKAEWDATFKLKDDPRITKIGQFLRRTSLDELPQLFNVLKGEMSLVGPRPIITAELERYNDEVDYYLLSKPGMTGLWQVSGRSDVDYDTRVYLDAWYVKNWSMWNDIAILFKTIGVVLKKDGAY	MMMLSRWRRSAVVLRIAAALLSPLAVAIPAHADAIANAANAVAPKIVERADWGKYFDAEGAKGTIIVLDGRTGGYQAYDSTRANQRMSPASTYKIFNSLLALESGALDNEREIIPWDGKPRSMKRWNAAMNLRDAFRVSCLPCYQVVSRKIARTYAQGKLDAVGYGNHTIGSAADAYWVDNSLQISAREQVVFLQRLARGQLPFSARTQDIVRQISIAEANMDYVLHGKTGWYVDGKHDIGWWVGWIERDGNITTVALNMDMRSDADAPKRARIARAVLKDLKLI	167.02	gnl|BL_ORD_ID|2590|hsp_num:0	3421			165	417	cloxacillin; oxacillin; cefalotin
BGC0000730.1|Capsular_12 # 12060 # 13292 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=AAGGAA;rbs_spacer=6bp;gc_cont=0.313	BGC0000730.1|Capsular_12 	12060	13292	+	Loose	1900	30.0314	AcrF	33.82	3000502	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGGACACTTTCGAAAGCGATAATAATATTATCATTAATTTTTTCTGTAACAAATTACGTGCCAATTAGTGTCTTAGTGCTCTTACTAACACCTATTTCGGTAATAGGTATTTTTTACAGAACTGATTTTTTAAAATTTAAAAAAATTGAGCTTTATCTTTTATTGTTATATATCTACGTTATTGGCTCAACGTTAATATATAACCCAAGCTCTTTCTTAGAATTTGATTTTTATAGAAAAGATGGGAATTTTATAATTAGCTATTTAATATTACTGGTATTTATATTTTTACCATTAAATATTGATATTGATATTGATAAATGGCTCAAACGGGCATTTGTCATTTTTTCGATAGCTTCATTCGTTGCCTTTCTTATAATGCCAAAAGAAGTCCCGGAAGAAGGCGGTGCTACAGTGCATCATTTCTTCTTTTTATCGCATAATGCTGCGGGGGGCTTTTATTCAGTAATTGGGGCAATGGCCTTAGGGATATATCTGCATAGTAAGAATAAGTTATATTTATTTTATGCTATTATGTTTATCTTTTTCTTGTATATGACCAATTCGAGAGGAAGCATTCTGGCCATAATGGCTGCCTTTGGATATTCCTTAATAAAATTCAAAAAACCGTTTCTTGTATTTACAATATTTTTACTCATTCAGTTTTTTATAGTTCAAGAAACATATCCAACATGGGTATCAATGGGTAAGATTATGTCTGAAAATGCAAATTATACTGTATCCAGTGCCGCCCAAGGTATAGACTTCCAGAGGGTAGGGACATTCATTGATCGGTTATATTATTTGTGGCCAAGGGCTTTTGATAATTTTATTCATTCACCATTACTAGGACTAGGTTTTGGTAGTTATGATGATTTATATTATCGATATTCAGATGTAATACCGCATTTATTAGCAATTAAAGAAGGAGCTATGGTAAGACATTCTGAAGCCCATGCACATAATTCAACATTTACAATCCTTGCAGAATTAGGTGTTGTAGGGTACCTCCTTTTTATTTTATTGTTTAATGAAATTAATAAAAAAATAATTGCTATAAAAAAAGTTGAACCTGGTATATTTATGGCCTTAAGCTTAGCATTTTGGACATGCATATTTTCATCGGCGACTGAGCATCGTATAACAACCCCTTCACAAATGATACCCTTTTTTATATTATTTGGGATATGCTATCTGAAATTTTTCGGAAGAAGGAATGTAAATGATTAA	MRTLSKAIIILSLIFSVTNYVPISVLVLLLTPISVIGIFYRTDFLKFKKIELYLLLLYIYVIGSTLIYNPSSFLEFDFYRKDGNFIISYLILLVFIFLPLNIDIDIDKWLKRAFVIFSIASFVAFLIMPKEVPEEGGATVHHFFFLSHNAAGGFYSVIGAMALGIYLHSKNKLYLFYAIMFIFFLYMTNSRGSILAIMAAFGYSLIKFKKPFLVFTIFLLIQFFIVQETYPTWVSMGKIMSENANYTVSSAAQGIDFQRVGTFIDRLYYLWPRAFDNFIHSPLLGLGFGSYDDLYYRYSDVIPHLLAIKEGAMVRHSEAHAHNSTFTILAELGVVGYLLFILLFNEINKKIIAIKKVEPGIFMALSLAFWTCIFSSATEHRITTPSQMIPFFILFGICYLKFFGRRNVND	MANFFIRRPIFAWVLAIILMMAGALAILQLPVAQYPTIAPPAVSVSANYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSYLMVAGFVSDNPGTTQDDISDYVASNVKDTLSRLNGVGDVQLFGAQYAMRIWLDADLLNKYKLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRFKNPEEFGKVTLRVNSDGSVVRLKDVARVELGGENYNVIARINGKPAAGLGIKLATGANALDTAKAIKAKLAELQPFFPQGMKVLYPYDTTPFVQLSIHEVVKTLFEAIMLVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMMEDKLPPKEATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATLLKPVSAEHHENKGGFFGWFNTTFDHSVNHYTNSVGKILGSTGRYLLIYALIVAGMVVLFLRLPSSFLPEEDQGVFLTMIQLPAGATQERTQKVLDQVTDYYLKNEKANVESVFTVNGFSFSGQAQNAGMAFVSLKPWEERNGDENSAEAVIHRAKMELGKIRDGFVIPFNMPAIVELGTATGFDFELIDQAGLGHDALTQARNQLLGMAAQHPASLVSVRPNGLEDTAQFKLEVDQEKAQALGVSLSDINQTISTALGGTYVNDFIDRGRVKKLYVQADAKFRMLPEDVDKLYVRSANGEMVPFSAFTTSHWVYGSPRLERYNGLPSMEIQGEAAPGTSSGDAMALMENLASKLPAGIGYDWTGMSYQERLSGNQAPALVAISFVVVFLCLAALYESWSIPVSVMLVVPLGIVGVLLAATLFNQKNDVYFMVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGVVEATLMAVRMRLRPILMTSLAFILGVLPLAISNGAGSGAQNAVGIGVMGGMVSATLLAIFFVPVFFVVIRRCFKG	39.65	gnl|BL_ORD_ID|1353|hsp_num:0	1437			1029	1233	ciprofloxacin
BGC0000730.1|Capsular_13 # 13285 # 13803 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AAGGAA;rbs_spacer=5bp;gc_cont=0.308	BGC0000730.1|Capsular_13 	13285	13803	+	Loose	400	36.1946	Agrobacterium fabrum chloramphenicol acetyltransferase	32.08	3004451	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGATTAAATGGATTAATATGTTTTATAGAGAAATAAGATCTCAGCCAGTTTTAAAAAGTAAGGTGATAATATTTTTATACAGATTATCATCTTTATTCTTTAGCCAATCTAGAAACCCCCTAAAATATATATTCATTATTTTTGTTTTTTCTTACTATTGCGTTGTAGAGTTTCTATGGGGTATTGAAATAAAGCCTAAGACAAAAATCGGTTGGGGTATAAAAATTTTTCATCCTAATTCGATAATTATAAATCCTGGTGCAGTATTAGGTAGTGGGGTTATATTAAGACATGGTGTCACAATCGGGAATAAATATAATAAAAAGACTGGGCGTGAAACAAAATGTCCTATAATTAAAGATAATGTCGAATTTGGGGCATATGCTTGTGTAATCGGTGAAATAGTTGTAGGTGAGGATTCGATAATAGGTGCTATGAGCTACGTAGATTTCGATGTAGAGGCTTATTCAATAATATCATCTCATCGCGGTATAGTATTAAGGAAGAAAAATGCATAA	MIKWINMFYREIRSQPVLKSKVIIFLYRLSSLFFSQSRNPLKYIFIIFVFSYYCVVEFLWGIEIKPKTKIGWGIKIFHPNSIIINPGAVLGSGVILRHGVTIGNKYNKKTGRETKCPIIKDNVEFGAYACVIGEIVVGEDSIIGAMSYVDFDVEAYSIISSHRGIVLRKKNA	MENYFESPFRGITLDKQVKSPNLVVGKYSYYSGYYHGHSFEDCARYLLPDEGADRLVIGSFCSIGSGAAFIMAGNQGHRNEWISTFPFFFMPEVPEFENAANGYLPAGDTVIGNDVWIGSEAIIMPGITVGDGAVIGTRALVTKDVEPYAIVGGNPAKTIRKRFDDDSIALLLEMKWWGWPAERLKAAMPLMTSGNVAALYRFWRSDSL	82.30	gnl|BL_ORD_ID|2500|hsp_num:0	2890			330	489	chloramphenicol
BGC0000730.1|Capsular_15 # 14656 # 15789 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=7bp;gc_cont=0.321	BGC0000730.1|Capsular_15 	14656	15789	+	Loose	700	26.5646	LpsB	22.82	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGAAAGTGTTGCATATATCAGATAGTTATGAAGGTGGTGGTGCTGAGGCTGTATTGCGAGATACTATAAAGGTTTGTGAAGAGCTAGGATACCAAAATGAGATTTTTGTTTCACAAGGAAAAACAACCATTATTTCTTATGTTTTCTCTATAGGTTACTATGAAAAACTTTTGGAAAAATTAATAGATTTCAAACCAGACATCGTTCATCTACATAATTATTATCATTACCTCTCTCCATCGGTATTATATGCGTTAAAGAAATATAAAAAAAGAACAAGAATTAAAATTATATTCACTGCTCATGACTACCATATAATTTGTCCTAACAGTGGTTTTCAATACTTTAAAGATAATAAAAGATTTAATTTTGATTATAACAGGAAAGAGTCAACTTTATTCAGGAAATTTGATCATCGGTCATATGCACATTCGCTCCTTAAAGTCATGCAACACACTATATGCTATAATTTTTTAAATTTGAGAGAAGTTATTGATATTATCATTTCACCAAGCCATTTTATGAAGTCTACGTTATCAAATTATGGTATAACCAAACCAATAAGCGTTATTAGAAATCCGGTTTCTATAGCTAATACGGAGCGGCAGATTTTGTTGAATGATGGCTCAATTCATATAGTATATGTGGGGCGATTGACTCCTGAAAAAGGTATAGTAGAGTTTATTAAAAAAGTAAATCATGAAACAACACAAGTCATTCATTTACATATTTATGGCGCTGGTGAGTCAGCGGAGGAAATTAAATCTATCAAGTGTAGGGAAGGTTTCAAGATTCTTTTTCACGGTTTTATTGATAGAGATTTACTGATTACAGAAATCTCAAAATACCATATTTTTGTGTTGCCTTCTATATGGTTAGAAAATGCTCCTGTTTCGATTGTTGAAGCAGCCGAAGCTGGTTTACCAGTTATTGTGCCTAATTATGGAGGGTTGGCGGAAATGGCAGAAGAAACATTGTATAATTACAAATTTGATTATGAAGATAGTGACCTTTCTGAGGTCATTACACAAGCGGCTGATAAGAAAGGTAAGAATAAGCTAAATAACCCTGATAGTTTCTCGTACGAGATGTACAAAGAAAGCATTAAAAAAATATATTCTCAATCTTTCTAG	MKVLHISDSYEGGGAEAVLRDTIKVCEELGYQNEIFVSQGKTTIISYVFSIGYYEKLLEKLIDFKPDIVHLHNYYHYLSPSVLYALKKYKKRTRIKIIFTAHDYHIICPNSGFQYFKDNKRFNFDYNRKESTLFRKFDHRSYAHSLLKVMQHTICYNFLNLREVIDIIISPSHFMKSTLSNYGITKPISVIRNPVSIANTERQILLNDGSIHIVYVGRLTPEKGIVEFIKKVNHETTQVIHLHIYGAGESAEEIKSIKCREGFKILFHGFIDRDLLITEISKYHIFVLPSIWLENAPVSIVEAAEAGLPVIVPNYGGLAEMAEETLYNYKFDYEDSDLSEVITQAADKKGKNKLNNPDSFSYEMYKESIKKIYSQSF	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	103.01	gnl|BL_ORD_ID|2781|hsp_num:0	3793			0	930	colistin A; colistin B; defensin
BGC0000730.1|Capsular_16 # 15816 # 17066 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=10bp;gc_cont=0.333	BGC0000730.1|Capsular_16 	15816	17066	+	Loose	960	29.261	efrA	26.83	3003948	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; rifamycin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGGAAAATTATCAGTCTTAGTGTTACTAATAGTACAGGCTTTTTATTTTAGTACACAGGTATCTGCAGTCACATTTAGTGACCTTAATGGTTCCAATGGAATCTCCTCTCCAGAACTTTCGAAAAAACAAGGGATTAGTATAATCAGAATAGATGTTCCATGGAGTGAAATCGAATCGGTAAAGGGGAATTATGATTATACAAAATATGATAATGAAATTATTAGGGCCAAAAAATTAGGTTACGATGTTCTACCTGTACTTGCATATGCTCCTGTTTGGAACAAAAGTATTAAAGGTAAAATTGGCTCACCTCCTCTTGAAACATCTTCATGGAATGGATTTGTTGAATCTACAGTAAAACGTTATCGTGCATACCCGTATAATATTACTTATTTCCAAGTCTGGAATGAGCCTACTTTGAAGGCCAAATTTTGGTTGGGAAATAATGAAGATTTTGTGAATAAAATCTATATACCCGCTGCAAAAATCATAAAGAAAAACAACGGCAAGGTAGTGTTTGGCGGTTGGCCACTATCCAATAGTATAAGTGAGTTTGATTATGTATTGGAGGGTTTAGGTGCTATAAAGTATACGGATATAATTGATATTCATTACCGAGGTTATAAATCCTATATAAAACTATATGATAAGTATATCAAAACAAATAAAGCAGACGGAATTTGGCAAAGTGAATTAGGATATTCATCGAAACCTGGAAATTTGCTGTCTTCGTACCTTAAAATCATGAGTTGGGCGCTTAGTCATAATTGGGCAAAATCAGATACTTATAAAATTTTTTGGTATCCAGCTTGGGCAAGTCGTGAAAAAAAGCAATATGGCTTAGCTACAACACTAAAAGATGGAACTACAGTTCTCACTGAAAATGGTAATGAGCTTGTCTTATTAAATGACTTATACGGTTCTGGTGAACTAGCGGTTCAAGATGTACAAAGTAATATGAAAAGCTCAATTGATACTGATGATTATTTTTTCGGAGTGAAAATTAGTCCAAACAGGATAGTTATTGCCGTGCTATATAATGGACACGATGATTATAATCAACTGAATTATTCCCTTATGACAAAAAATAACCCTCGGCATATAACTTTAGTTTCATCTAAGAGAAAACAATATCAATTAGATCACACTTATGAAAAGGGGGTTACTCATATATTTGTTGATAAAGATAAGATTCGCAGCATTTCAAAAGGTTATAGTGATGTATTCTTTATTAAGGTAGAGCTTTAA	MGKLSVLVLLIVQAFYFSTQVSAVTFSDLNGSNGISSPELSKKQGISIIRIDVPWSEIESVKGNYDYTKYDNEIIRAKKLGYDVLPVLAYAPVWNKSIKGKIGSPPLETSSWNGFVESTVKRYRAYPYNITYFQVWNEPTLKAKFWLGNNEDFVNKIYIPAAKIIKKNNGKVVFGGWPLSNSISEFDYVLEGLGAIKYTDIIDIHYRGYKSYIKLYDKYIKTNKADGIWQSELGYSSKPGNLLSSYLKIMSWALSHNWAKSDTYKIFWYPAWASREKKQYGLATTLKDGTTVLTENGNELVLLNDLYGSGELAVQDVQSNMKSSIDTDDYFFGVKISPNRIVIAVLYNGHDDYNQLNYSLMTKNNPRHITLVSSKRKQYQLDHTYEKGVTHIFVDKDKIRSISKGYSDVFFIKVEL	MKLMWRYTMRYKKLLFADFICVFGFILIELGLPTILARMIDKGIIPKDMDYVYQQGIWMVVITIIGVAMNILLGYFGARITTNIVRDIRDDLFEKIQTFSHSEYESIGVSSLITRTTNDAYQIMLFMGNILRLGFMTPVMFIASLYMVMRTSPSLGMYVLGALPFLLLAVVGIARLSEPLSKKQQKNLDGINGILRENLSGLRVIRAFVNEKFEESRFNKVNETYTKSSKSLFRLMAAAQPGFFFLFNIVMVLIIWSGTVQISHGDLEVGNLIAFIEYIFHALFSFMLFASVFMMYPRAAVSASRIQEALDMEPAIREEEGVTETATKGYLEFKNVTFAYPGHAESPVIRNVSFKASPGETVAFIGSTGSGKSTLIQLIPRFYDVSEGEILIDGVNVKEYKLSALRNKIGYIPQKALLFTGTIADNLRYGKEDATLEEMERAIDIAQATEFVSQKPQGYDEPLSEGGTNFSGGQKQRLAIARAIIRNPEIYIFDDSFSALDYQTDANLRARLKKETTESTVLIVAQRVGTIMHADRIVVLNEGDVVGIGTHRELLETCPIYYDIAASQLSEEELA	72.35	gnl|BL_ORD_ID|2182|hsp_num:0	2421			477	831	erythromycin; ciprofloxacin; rifampin
BGC0000730.1|Capsular_17 # 17254 # 18417 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.355	BGC0000730.1|Capsular_17 	17254	18417	+	Loose	700	35.8094	LpsB	28.16	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGCTACAAAATGTTAGTGTTGGTCTTGTTGCTGATTGGTTAGTAACTTATGCAGGATCGGAAAAAGTTATTGCAGAATTTATAAAACTGTTTCCCCAGTCTGATCTTTATTCAGTTATTGATTTTCTTTCGGATGAATCTCGAAGTCGATTTATGAATAAACGAGCAAAAACAACTTTTATTCAAAAATTACCTAAGGCAAAAAGTAACTACCAGCGATACTTACCATTCATGCCACTTGCTATAGAACAATTGGATGTTTCAAAGCATGAAATCATTCTCTCTAGTAGCCATGCAGTGGCCAAAGGGATATTAACAGGTCCTGATCAATTGCATATAAGCTATGTTCATTCTCCAATTCGTTATGCTTGGGATTTACAACACCAATATTTAAGAGAAGCAGGCCTTGATAAAGGCATTAAATCATATATAGCACGGATGCTTTTGCATAAAATTAGATTGTGGGATTGCCGTACTGCTAATGGTGTAGATCACTTCATTGCAAATTCTCAATTCATTGCGCGACGTATCAAAAAAGTATATGGTCGTGATGCTGATGTTATTTATCCTCCTGTTGATGTAAATAGATTTGAATTAAATTTTAATAAAGAAGATTATTTTTTCACTGCATCTCGATTGGTACCATATAAGAGGATTGATTTGATCGTTGAGGCCTTTTCGGAAATGCCCAATCGAAAATTGGTTGTGATTGGGGATGGTCCCGAGATGCAAAAAATTAAAAGTAAGGCTAAGACAAACATTGAAATTTTAGGTTATCAACCTGATTCAGTCATGCAGGAATATATGCGTAACGCTAAAGCATTTGTTTTTGCTGCAGAAGAGGATTTTGGTATTATACCCGTAGAGGCTCAGGCTTGCGGGACACCAGTTATTGCATTTGGTAAGGGGGGGGCACTGGAAACTATTCGCCCTCTTGGTGTTGATAAACCCACTGGATTATTCTTTCAGAAACAAACTGTGGCAGATATAATTGAAGCGGTTACTAATTTCGATAATAATTTTGAATCATTTAATCTTCATGATTGCAGGAACAATGCAGAAAAATTCTCTGTGGAAAGATTTAACAACGAAATTTTAAATTATATTACTGACAAGTACGAATCATTCAAATTGAAAGGTACGTCTGGGGTTTGTAATATATAA	MLQNVSVGLVADWLVTYAGSEKVIAEFIKLFPQSDLYSVIDFLSDESRSRFMNKRAKTTFIQKLPKAKSNYQRYLPFMPLAIEQLDVSKHEIILSSSHAVAKGILTGPDQLHISYVHSPIRYAWDLQHQYLREAGLDKGIKSYIARMLLHKIRLWDCRTANGVDHFIANSQFIARRIKKVYGRDADVIYPPVDVNRFELNFNKEDYFFTASRLVPYKRIDLIVEAFSEMPNRKLVVIGDGPEMQKIKSKAKTNIEILGYQPDSVMQEYMRNAKAFVFAAEEDFGIIPVEAQACGTPVIAFGKGGALETIRPLGVDKPTGLFFQKQTVADIIEAVTNFDNNFESFNLHDCRNNAEKFSVERFNNEILNYITDKYESFKLKGTSGVCNI	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	105.74	gnl|BL_ORD_ID|2781|hsp_num:0	3793			630	933	colistin A; colistin B; defensin
BGC0000730.1|Capsular_18 # 18699 # 19958 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AAGGA;rbs_spacer=5bp;gc_cont=0.312	BGC0000730.1|Capsular_18 	18699	19958	+	Loose	810	29.261	cdeA	26.83	3003835	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGAAAAAAAATAGTATTATTAATGCAGCTTGGATGATGTCTGAAAAGATAGTAACTTTATTTGGGTTGTTTTTTGTTACTTCATTTGTTGCTAAATACATCGGTCCTTTCCGATTCGGTCAACTAGCTTTAGCTATTGCCATATTTCAAGTTATTCAAGTAATAGCTCAGTTAGGTTGTGATAATATTATTTTTAAGCGTGTTTCGGAAAAGGTTTTATCTGGTCTAAAACTGATTTATTCTACCTTTCTTATTCGTGGTGGGATATATTTTATATTATCTTTTTTTGTGCTTTTGTTTTTTTATAATAAAAGTGATGTTATTAATTATGTATTTTTGATTTCTGTGTGTTTAGCATGTTTTTTTACGTCTATGGACGTTTTTACTATATATAATGATGCGACTCTAAATTCGAAGTTCAACACTATTGCCAACGTGATCGGATTGCTTATTGGTTTGATTTTACGCTACGTTATCGCTTTTTTTGAATGGCCAATTTATTTTTTAGCTATACCAATAGTACTAACCACCTTAATCCCTTTTTTAATCCGACTTGTCTATACACCAAAGGTATATGTTGTTAAAGGAAAGAATAAATGGCGCTATAACAAATATCTCTTTACAACCGGAATACCATTGGTGATATCTACAGTTTCAATGACTCTTTACTCAAGAATAAATCAGTTCACACTTTCTTACTTTGATGGCAGCTATGAACTTGGTATCTACTCTGTTGCACTAACACTCGGGACCGCCTGGGTTTTCATAGGTAACGCTCTTGCAATTTCATTCCTTTCGAAGATATATTCTGAGAAAGACGACTTGAAAGCCCAGGATAAAACATCGGGTTTATTATCTTTTGTTTTTATTATTTTGTCAGTATTTCCACTGTTTTTTTATTTTTTTGGAAAAAAAGTGATTTTATTACTCTATGGAGAGCAATATGTTAATTCTTATGGGATAATAATCATATTGTGTATTTCGACCGTTATAACGGCAATGGGTTTTATATCCAATAGGTATATAGTTAGATTGTCAGGGTATAAATATTTATCAAAGAAAACCCTTTTGGTTTTGGGGTTGAGTATACCCATTTCAACAACCATGGTATATTTTTTTGGAGTATATGGTGCTGCTTATAGCGTTCTAATTGTAGAATTTTTATCCTTAACTATTATGAATTATTTTTTCAATCATGGAGTTATTCTGAAAGTTCATAGAGGTGCTTTTAATTTAAAAAAGATCGCCTCGCTGAGATAA	MKKNSIINAAWMMSEKIVTLFGLFFVTSFVAKYIGPFRFGQLALAIAIFQVIQVIAQLGCDNIIFKRVSEKVLSGLKLIYSTFLIRGGIYFILSFFVLLFFYNKSDVINYVFLISVCLACFFTSMDVFTIYNDATLNSKFNTIANVIGLLIGLILRYVIAFFEWPIYFLAIPIVLTTLIPFLIRLVYTPKVYVVKGKNKWRYNKYLFTTGIPLVISTVSMTLYSRINQFTLSYFDGSYELGIYSVALTLGTAWVFIGNALAISFLSKIYSEKDDLKAQDKTSGLLSFVFIILSVFPLFFYFFGKKVILLLYGEQYVNSYGIIIILCISTVITAMGFISNRYIVRLSGYKYLSKKTLLVLGLSIPISTTMVYFFGVYGAAYSVLIVEFLSLTIMNYFFNHGVILKVHRGAFNLKKIASLR	MENLFTRKFTTFEFLKFVSPAIISMIFISLYTIIDGIFVSTLVGSDALASINIVLPIINLVCGFGIMMATGGGAIVSIRMGENRQDEANSTFSFIVLFSLIVGILFTVISYFFIKEISILLGATDKLLPYCITYGKVMILCTPFYILKFIFEYFARTDGNSKFSLFLSVIGGVTNIILDYVFIKYFGMGLLGAAVATAIGIILTCVLGIIYFLSNKSTLKLRKPKTDFRLIRDTMINGSSEMVTELSTGITTFLFNVVALKLAGENGLAALTIVLYAHFLMTSVYLGFAAGVSPLISYNFGAENSDKLKETFKHSLKFIFISSLLVFIIALVFAPFIVRVFVNPDNTVFKLALQGLKIFAFAFLFVGINIFASGFFTAFHNGKISAIISFSRAFVFIIIGIIILPPMLNMTGLWLTVPFAEVITIFISILFIKKYKGRYKY	95.01	gnl|BL_ORD_ID|2083|hsp_num:0	2321			57	423	acriflavine
BGC0000730.1|Capsular_19 # 20596 # 21786 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.510	BGC0000730.1|Capsular_19 	20596	21786	+	Loose	125	28.4906	vanXY gene in vanN cluster	31.67	3002969	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanXY	ATGGTGAAGGCCGGGTCTGGCACCGACAGCGCCATCGATTCCCTGAAGCCTTACCTCGATAAAGGCGACATCATCATTGATGGCGGCAACACCTTCTTCCAGGACACCATCCGTCGTAACCGTGAATTGTCTGCCGAAGGTTTTAACTTTATCGGTACCGGTGTTTCCGGTGGTGAAGAGGGTGCTCTGAAAGGGCCTTCCATCATGCCTGGTGGGCAGAAAGAAGCCTATGAGCTGGTTGCGCCGATTCTGAAGCAGATTGCTGCCGTTGCTGAAGACGGTGAGCCATGTGTGACCTATATCGGTGCTGATGGTGCGGGCCATTATGTGAAGATGGTTCATAACGGCATCGAGTATGGTGACATGCAGTTGATTGCTGAAGCCTATGCGCTGTTGAAAGGCGGTCTGACACTTTCCAACGAAGAGCTGGCGCAAACCTTCACTGAATGGAACGAAGGCGAGCTAAGCAGCTACCTGATCGACATTACCAAAGATATCTTCACCAAGAAGGATGAAGAAGGTAAGTACCTCGTTGATGTCATTCTTGATGAAGCAGCAAACAAAGGTACCGGTAAGTGGACCAGCCAGAGCTCACTGGATCTCGGCGAACCTCTGTCTCTGATCACCGAATCCGTATTTGCTCGTTACATCTCTTCGCTTAAAGACCAGCGTGTAGCTGCTTCGAAAGTGCTGAGTGGTCCGCAGGCTCAACCGGCCGGTGATAAAGCTGAATTTATCGAAAAAGTGCGTCGCGCGTTGTACCTCGGTAAAATCGTCTCCTATGCTCAGGGTTTCTCCCAGCTGCGTGCTGCTTCTGATGAATACAACTGGGATCTTAACTACGGCGAGATCGCTAAGATTTTCCGCGCTGGCTGCATCATTCGTGCGCAGTTCCTGCAAAAGATCACCGATGCTTATGCGCAAAACGCTGGCATTGCTAACCTCCTGCTGGCGCCGTACTTCAAACAGATCGCTGATGACTATCAGCAAGCGCTGCGTGATGTCGTGGCTTATGCCGTGCAGAATGGTATTCCGGTACCGACGTTCTCAGCCGCGATTGCTTACTACGACAGCTACCGTTCCGCAGTTCTGCCAGCTAACCTGATTCAGGCTCAGCGTGATTACTTTGGTGCGCACACATATAAGCGTACTGATAAAGAAGGTATATTCCATACCGAGTGGTTGGAATAA	MVKAGSGTDSAIDSLKPYLDKGDIIIDGGNTFFQDTIRRNRELSAEGFNFIGTGVSGGEEGALKGPSIMPGGQKEAYELVAPILKQIAAVAEDGEPCVTYIGADGAGHYVKMVHNGIEYGDMQLIAEAYALLKGGLTLSNEELAQTFTEWNEGELSSYLIDITKDIFTKKDEEGKYLVDVILDEAANKGTGKWTSQSSLDLGEPLSLITESVFARYISSLKDQRVAASKVLSGPQAQPAGDKAEFIEKVRRALYLGKIVSYAQGFSQLRAASDEYNWDLNYGEIAKIFRAGCIIRAQFLQKITDAYAQNAGIANLLLAPYFKQIADDYQQALRDVVAYAVQNGIPVPTFSAAIAYYDSYRSAVLPANLIQAQRDYFGAHTYKRTDKEGIFHTEWLE	MHNFYLQLVNQQHPWKSFNHSPQLVQATYAEEKILIDSKVNHQFNQLLETLQLTDRIMIVDGHRTVAEQKHLWNYSLNAHGVNYTKSYVASPGCSEHHTGLAIDLGLRKTEHDLIAPRFEGPEAELFLQHMKDYGFILRYPKNKQKITGIAYEPWHFRYVGTPHSQIIMDHGWTLEEYIEFLKHQIEAVS	208.42	gnl|BL_ORD_ID|4733|hsp_num:0	518			171	351	vancomycin
